Vasu R. Sah

Oncology R&D
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases.

Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases.

Journal: eLife

Published: September 23, 2024

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro.

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro.

Journal: Frontiers in cell and developmental biology

Published: June 12, 2023

Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.

Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.

Journal: Cancer research communications

Published: December 01, 2022

Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer.

Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer.

Journal: Journal for immunotherapy of cancer

Published: February 21, 2022

Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma.

Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma.

Journal: Melanoma research

Published: November 10, 2021

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma.

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma.

Journal: Nature communications

Published: March 28, 2021

Molecular profiling of driver events in metastatic uveal melanoma.

Molecular profiling of driver events in metastatic uveal melanoma.

Journal: Nature communications

Published: July 02, 2019

The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment.

The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment.

Journal: Journal for immunotherapy of cancer

Published: April 12, 2017

Toxicology Study of Single-walled Carbon Nanotubes and Reduced Graphene Oxide in Human Sperm.

Toxicology Study of Single-walled Carbon Nanotubes and Reduced Graphene Oxide in Human Sperm.

Journal: Scientific reports

Published: January 29, 2016

Bacteria inside semiconductors as potential sensor elements: biochip progress.

Bacteria inside semiconductors as potential sensor elements: biochip progress.

Journal: Sensors (Basel, Switzerland)

Published: April 09, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026